Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Collierville, Tennessee Clinical Trials

A listing of Collierville, Tennessee clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Phase

7.66 miles

Learn More »

A Study Assessing the Efficacy and Safety of CBP-201

This is a randomized, double-blind, placebo-controlled, dose regimen finding study to assess the efficacy, safety, and steady-state PK profile of CBP-201 administered to eligible adult subjects with moderate to severe atopic dermatitis compared to placebo. CBP-201 is administered as a subcutaneous (SC) injection. The study is divided into a treatment …

Phase

9.69 miles

Learn More »

Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

The purpose of this study is to evaluate the long-term safety of BHV-3500/vazegepant intranasal in the acute treatment of migraine. BHV-3500, formerly "vazegepant", is now referred to as "zavegepant" (za ve' je pant). The World Health Organization (WHO) International Nonproprietary Names (INN) Expert Committee revised the name to "zavegepant" which …

Phase

9.69 miles

Learn More »

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

Subjects will come for 4 visits: Screening (visit 1), baseline (visit 2), after 4 treatment weeks from baseline (visit 3) and after 8 treatment weeks from baseline (Final visit , visit 4). A total of 8 treatment weeks Three arms will be assessed: Vibrant Capsule mode A administered 5 times …

Phase N/A

9.69 miles

Learn More »

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

The purpose of this study is to compare the efficacy and safety of a new artificial tear formulation with Systane Ultra Multidose for 90 days in participants with Dry Eye Disease (DED).

Phase

9.69 miles

Learn More »